Chevy Chase Trust’s Elevance Health ELV Stock Holding History

Chevy Chase Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.9M	Sell	109,111 -3,954	-3%	-$1.3M	0.09%	191
2025 Q4	$39.6M	Sell	113,065 -2,237	-2%	-$756K	0.11%	157
2025 Q3	$37.3M	Sell	115,302 -4,620	-4%	-$1.44M	0.1%	173
2025 Q2	$46.6M	Sell	119,922 -2,695	-2%	-$1.08M	0.14%	143
2025 Q1	$53.3M	Buy	122,617 +239	+0.2%	+$95.9K	0.17%	119
2024 Q4	$45.1M	Sell	122,378 -2,608	-2%	-$1.09M	0.14%	130
2024 Q3	$65M	Sell	124,986 -2,559	-2%	-$1.37M	0.2%	97
2024 Q2	$69.1M	Sell	127,545 -3,231	-2%	-$1.71M	0.22%	92
2024 Q1	$67.8M	Sell	130,776 -1,131	-0.9%	-$562K	0.22%	95
2023 Q4	$62.2M	Sell	131,907 -1,007	-0.8%	-$466K	0.22%	95
2023 Q3	$57.9M	Sell	132,914 -3,932	-3%	-$1.78M	0.23%	97
2023 Q2	$60.8M	Sell	136,846 -2,441	-2%	-$1.13M	0.23%	99
2023 Q1	$64M	Buy	139,287 +1,377	+1%	+$655K	0.25%	95
2022 Q4	$70.7M	Sell	137,910 -9,193	-6%	-$4.67M	0.3%	85
2022 Q3	$66.8M	Buy	147,103 +1,003	+0.7%	+$480K	0.29%	81
2022 Q2	$70.5M	Sell	146,100 -592	-0.4%	-$293K	0.29%	82
2022 Q1	$72.1M	Buy	146,692 +778	+0.5%	+$356K	0.25%	95
2021 Q4	$67.6M	Sell	145,914 -3,787	-3%	-$1.59M	0.22%	103
2021 Q3	$55.8M	Sell	149,701 -6,705	-4%	-$2.55M	0.19%	115
2021 Q2	$59.7M	Sell	156,406 -7,962	-5%	-$3.04M	0.2%	112
2021 Q1	$59M	Sell	164,368 -15,194	-8%	-$4.89M	0.21%	111
2020 Q4	$57.7M	Sell	179,562 -6,977	-4%	-$2.14M	0.21%	113
2020 Q3	$50.1M	Sell	186,539 -16,642	-8%	-$4.48M	0.2%	113
2020 Q2	$53.4M	Sell	203,181 -12,622	-6%	-$3.37M	0.22%	106
2020 Q1	$49M	Buy	215,803 +3,651	+2%	+$995K	0.23%	104
2019 Q4	$64.1M	Sell	212,152 -1,794	-0.8%	-$494K	0.24%	96
2019 Q3	$51.4M	Sell	213,946 -1,054	-0.5%	-$289K	0.21%	109
2019 Q2	$60.7M	Buy	215,000 +225	+0.1%	+$61.5K	0.25%	94
2019 Q1	$56.6M	Buy	214,775 +1,525	+0.7%	+$441K	0.23%	97
2018 Q4	$56M	Sell	213,250 -3,079	-1%	-$847K	0.27%	91
2018 Q3	$59.3M	Sell	216,329 -1,270	-0.6%	-$330K	0.25%	93
2018 Q2	$51.8M	Sell	217,599 -1,403	-0.6%	-$325K	0.22%	102
2018 Q1	$48.1M	Sell	219,002 -6,226	-3%	-$1.46M	0.21%	112
2017 Q4	$50.7M	Sell	225,228 -6,591	-3%	-$1.4M	0.22%	112
2017 Q3	$44M	Buy	231,819 +736	+0.3%	+$140K	0.2%	124
2017 Q2	$43.5M	Buy	231,083 +373	+0.2%	+$67K	0.21%	123
2017 Q1	$38.2M	Buy	230,710 +8,957	+4%	+$1.42M	0.19%	134
2016 Q4	$31.9M	Buy	221,753 +982	+0.4%	+$131K	0.17%	148
2016 Q3	$27.7M	Sell	220,771 -5,214	-2%	-$673K	0.15%	161
2016 Q2	$29.7M	Buy	225,985 +4,040	+2%	+$553K	0.17%	146
2016 Q1	$30.8M	Buy	221,945 +5,292	+2%	+$707K	0.18%	138
2015 Q4	$30.2M	Buy	216,653 +988	+0.5%	+$136K	0.18%	140
2015 Q3	$30.2M	Buy	215,665 +5,175	+2%	+$778K	0.19%	132
2015 Q2	$34.5M	Buy	210,490 +985	+0.5%	+$157K	0.21%	124
2015 Q1	$32.4M	Buy	209,505 +4,913	+2%	+$699K	0.2%	129
2014 Q4	$25.7M	Sell	204,592 -5,039	-2%	-$623K	0.16%	157
2014 Q3	$25.1M	Buy	209,631 +9,080	+5%	+$1.04M	0.16%	158
2014 Q2	$21.6M	Sell	200,551 -6,138	-3%	-$632K	0.15%	168
2014 Q1	$20.6M	Sell	206,689 -9,787	-5%	-$885K	0.15%	170
2013 Q4	$20M	Sell	216,476 -255	-0.1%	-$22.7K	0.15%	167
2013 Q3	$18.1M	Buy	216,731 +4,202	+2%	+$360K	0.15%	165
2013 Q2	$17.4M	Buy	+212,529	New	+$15.9M	0.15%	154

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Chevy Chase Trust's ELV Position: Q1 2026 in Review

Chevy Chase Trust reduced its Elevance Health (ELV) stake by 3.5% in Q1 2026, selling an estimated $1.3M and leaving 109,111 shares worth $31.9M. The position accounts for 0.09% of the portfolio, ranked #191.

Chevy Chase Trust first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $72.1M in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Chevy Chase Trust held 109,111 shares of Elevance Health worth $31.9M as of Q1 2026.
Chevy Chase Trust sold 3,954 Elevance Health shares in Q1 2026, an estimated $1.3M.
Elevance Health made up 0.09% of Chevy Chase Trust's portfolio in Q1 2026, its #191 holding.
Chevy Chase Trust first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
Chevy Chase Trust's Elevance Health position peaked at $72.1M in Q1 2022.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.